Connects consumers with licensed healthcare professionals through telehealth and sells men’s wellness products, including treatments for erectile dysfunction, hair loss and weight management, to patients.
Consumers buy products and services directly through the company’s website. Product sales are counted when products are delivered to a carrier; consultation services are counted over the few days the consultation takes place.
10-K for FY2025, filed Apr 1, 2026
$456K
10-K for FY2025, filed Apr 1, 2026
$456K ↗
Individual consumers use the company’s website to buy products and services, with prescriptions reviewed by licensed medical providers and orders fulfilled through a partner compounding pharmacy.
10-K for FY2025, filed Apr 1, 2026The Company follows the provisions of ASC 606. Revenue from Contracts with Customer for recording and recognizing revenue from customers.…View ↗
The Company recognizes revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to…View ↗
All Compounded Products are produced at and fulfilled by Epiq Scripts, LLC (“Epiq Scripts”), a related party compounding pharmacy, 52%…View ↗
No. It lost $20.6M in FY2025.
10-Q for Q3 FY2026, filed Nov 16, 2026
−$3.6MView ↗
8-K, filed Oct 1, 2026
Under the terms of the agreements, the investors have committed to purchase an aggregate 25% membership interest in MangoRx IP for $2.5…View ↗
8-K, filed Aug 21, 2026
On August 19, 2026, Mangoceuticals, Inc. (the “Company” or “MGRX”) and Nuclea Energy Inc. (“Nuclea”) mutually agreed to terminate that…View ↗
8-K, filed Jul 30, 2026
The exchange ratio is the product of (a) the Fully Diluted Mango Shares divided by the Fully Diluted Nuclea Shares, multiplied by (b) 24.…View ↗
Competes with Hims & Hers Health, Roman, Pfizer, Lilly ICOS, Merck &, and Johnson & Johnson
10-K for FY2025, filed Apr 1, 2026We mainly compete with other companies offering men’s wellness products, including Hims & Hers Health, Inc. and Roman, and with our Mango…View ↗
Loading...